Lesley Rigg believes that achieving the best outcomes requires community and connecting with others. Those principles guide her vision as Western’s vice-president of research, and underlie the message in Western Research’s new strategic plan, Mobili …
Robarts Clinical Trials Inc., a global academic clinical research organization with offices in San Diego, Amsterdam and London, Ont., announced today a relocation to the Bell Canada Building in downtown London, effective Jan. 1, 2016. The new corporate headquarters,...
Robert Bartha hopes his latest research will allow him to travel back in time when it comes to aggressively attacking neurodegenerative diseases such as Alzheimer’s, ALS and Parkinson’s. “Our ultimate goal is to try to find ways of early diagnosis. Understanding...
While not his main area of expertise, Chris Hudson has a vested interest in the neurodegenerative disorder research being explored at Robarts Research Institute. A leading researcher in ophthalmology, Hudson was diagnosed with early-onset Parkinson’s when he was 41...
Robarts Clinical Trials Inc. has been named a finalist in for the 2015 London Business Achievement Awards in the Innovation category. Sponsored by the London Chamber of Commerce, the awards celebrate “the best and brightest of the London business community” in...
Western Epidemiology and Biostatistics professor Allen Donner will deliver his lecture, Current Issues in the Design & Analysis of Cluster Randomization Trials, as the annual Carol Buck Lecture at 1:30-3:30 p.m. Friday, Dec. 5, in the Kresge Building K106. The...
Western Chemistry professor Joseph Gilroy and Robarts Research Institute postdoctoral scholar Andrea Di Sebastiano have been tapped as Western’s Petro-Canada Young Innovator Award winners for 2014. Gilroy looks to develop revolutionary chelating (i.e. metal binding)...
Aided by former graduate student Nadeem Ashraf, and a Himalayan flower, Robarts Research Institute scientist Michael Poulter may be getting to the root of a solution to epileptic seizures.
An inexpensive tool for assessing arteries inside the head may detect a potentially dangerous hole within the heart of some patients with an unexplained stroke, according to a Western researcher.
Catherine McCoy is thrilled to be doing something she hasn’t done in quite some time – sleep comfortably.
Western researchers have discovered a possible new target for treating movement disorders such as Huntington’s disease and Parkinson’s disease.
Actor and activist Martin Sheen toured Robarts Research Institute Tuesday afternoon, prior to his appearance at the Leaders in Innovation dinner, organized by the Schulich School of Medicine & Dentistry. While at Robarts, Sheen tried his hand at a tele-robotic system used for remote manipulation of a catheter, under the watchful eye of Schulich professor Dr. Geoffrey Pickering. The first of its kind system has been developed by Western graduate students Ali Tavallaei and Daniel Gelman.
Western defines excellence in many ways, but recognizes it with one award – the Western Award of Excellence.
Robarts Clinical Trials Inc., a global academic clinical research organization with offices in San Diego, Amsterdam and London, Ont., announced today a relocation to the Bell Canada Building in downtown London, effective Jan. 1, 2016. The new corporate headquarters,...
Robert Bartha hopes his latest research will allow him to travel back in time when it comes to aggressively attacking neurodegenerative diseases such as Alzheimer’s, ALS and Parkinson’s. “Our ultimate goal is to try to find ways of early diagnosis. Understanding...
While not his main area of expertise, Chris Hudson has a vested interest in the neurodegenerative disorder research being explored at Robarts Research Institute. A leading researcher in ophthalmology, Hudson was diagnosed with early-onset Parkinson’s when he was 41...
Robarts Clinical Trials Inc. has been named a finalist in for the 2015 London Business Achievement Awards in the Innovation category. Sponsored by the London Chamber of Commerce, the awards celebrate “the best and brightest of the London business community” in...
Western Epidemiology and Biostatistics professor Allen Donner will deliver his lecture, Current Issues in the Design & Analysis of Cluster Randomization Trials, as the annual Carol Buck Lecture at 1:30-3:30 p.m. Friday, Dec. 5, in the Kresge Building K106. The...
Western Chemistry professor Joseph Gilroy and Robarts Research Institute postdoctoral scholar Andrea Di Sebastiano have been tapped as Western’s Petro-Canada Young Innovator Award winners for 2014. Gilroy looks to develop revolutionary chelating (i.e. metal binding)...
Aided by former graduate student Nadeem Ashraf, and a Himalayan flower, Robarts Research Institute scientist Michael Poulter may be getting to the root of a solution to epileptic seizures.
An inexpensive tool for assessing arteries inside the head may detect a potentially dangerous hole within the heart of some patients with an unexplained stroke, according to a Western researcher.
Catherine McCoy is thrilled to be doing something she hasn’t done in quite some time – sleep comfortably.
Western researchers have discovered a possible new target for treating movement disorders such as Huntington’s disease and Parkinson’s disease.
Actor and activist Martin Sheen toured Robarts Research Institute Tuesday afternoon, prior to his appearance at the Leaders in Innovation dinner, organized by the Schulich School of Medicine & Dentistry. While at Robarts, Sheen tried his hand at a tele-robotic system used for remote manipulation of a catheter, under the watchful eye of Schulich professor Dr. Geoffrey Pickering. The first of its kind system has been developed by Western graduate students Ali Tavallaei and Daniel Gelman.
Western defines excellence in many ways, but recognizes it with one award – the Western Award of Excellence.